|
1
|
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
|
Nature
|
2011
|
3.30
|
|
2
|
Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.
|
Cancer Res
|
2003
|
3.02
|
|
3
|
Analysis of PALB2/FANCN-associated breast cancer families.
|
Proc Natl Acad Sci U S A
|
2007
|
2.41
|
|
4
|
High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
|
Cancer Res
|
2009
|
1.82
|
|
5
|
Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.
|
PLoS One
|
2011
|
1.78
|
|
6
|
Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
|
Cancer Res
|
2005
|
1.70
|
|
7
|
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.
|
Cancer Res
|
2002
|
1.64
|
|
8
|
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.
|
J Pathol
|
2013
|
1.38
|
|
9
|
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
|
Breast Cancer Res Treat
|
2008
|
1.36
|
|
10
|
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
|
J Pathol
|
2003
|
1.27
|
|
11
|
Array-CGH and breast cancer.
|
Breast Cancer Res
|
2006
|
1.26
|
|
12
|
Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
|
Clin Cancer Res
|
2005
|
1.17
|
|
13
|
Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
|
Genes Chromosomes Cancer
|
2011
|
1.06
|
|
14
|
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
|
Clin Cancer Res
|
2010
|
1.05
|
|
15
|
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
|
Breast Cancer Res Treat
|
2010
|
1.05
|
|
16
|
Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness.
|
Breast Cancer Res
|
2011
|
1.03
|
|
17
|
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
|
Breast Cancer Res
|
2014
|
1.03
|
|
18
|
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
|
Eur J Hum Genet
|
2008
|
1.00
|
|
19
|
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers.
|
BMC Cancer
|
2010
|
0.97
|
|
20
|
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
|
BMC Cancer
|
2010
|
0.95
|
|
21
|
Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material.
|
BMC Cancer
|
2007
|
0.94
|
|
22
|
Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
|
Mod Pathol
|
2008
|
0.94
|
|
23
|
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.
|
Ann Surg Oncol
|
2010
|
0.94
|
|
24
|
Deletion of exons 1a-2 of BRCA1: a rather frequent pathogenic abnormality.
|
Genet Test Mol Biomarkers
|
2009
|
0.93
|
|
25
|
Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features.
|
Blood
|
2003
|
0.93
|
|
26
|
HER2 gene amplification in patients with breast cancer with equivocal IHC results.
|
J Clin Pathol
|
2011
|
0.91
|
|
27
|
Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
|
Int J Cancer
|
2011
|
0.89
|
|
28
|
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
|
Breast Cancer Res Treat
|
2007
|
0.86
|
|
29
|
Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
|
PLoS One
|
2013
|
0.86
|
|
30
|
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.
|
Genes Chromosomes Cancer
|
2008
|
0.84
|
|
31
|
Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
|
Genes Chromosomes Cancer
|
2010
|
0.83
|
|
32
|
Platform comparisons for identification of breast cancers with a BRCA-like copy number profile.
|
Breast Cancer Res Treat
|
2013
|
0.81
|
|
33
|
SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets.
|
BMC Bioinformatics
|
2007
|
0.80
|
|
34
|
Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer.
|
Genes Chromosomes Cancer
|
2009
|
0.79
|
|
35
|
Delineation of chondroid lipoma: an immunohistochemical and molecular biological analysis.
|
Sarcoma
|
2011
|
0.75
|
|
36
|
[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible].
|
Ned Tijdschr Geneeskd
|
2011
|
0.75
|